Is the development of diabetes with antihypertensive therapy a problem?--Pro (Q36392685)

13 August 2017

1 reference

title

Is the development of diabetes with antihypertensive therapy a problem?--Pro (English)

1 reference

13 August 2017

3

Gianpaolo Reboldi

1 reference

13 August 2017

Paolo Verdecchia

1

1 reference

13 August 2017

Fabio Angeli

series ordinal

2

1 reference

13 August 2017

Roberto Gattobigio

series ordinal

4

1 reference

13 August 2017

language of work or name

1 reference

1 February 2006

1 reference

Journal of Clinical Hypertension

13 August 2017

published in

1 reference

13 August 2017

volume

8

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

120-126

1 reference

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Study on COgnition and Prognosis in the Elderly (SCOPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Diabetes and cardiovascular events in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Adverse prognostic significance of new diabetes in treated hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Management of dyslipidemia in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Impaired fasting glucose, blood pressure and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

Old antihypertensives and new diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.04587.X

10.1111/J.1524-6175.2006.04587.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference